Haematology Pathway Board Haematology Pathway Board

NCA Haematology Pathway Board (NCHPB)

North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration

Haematology Pathway Board

The NCA Haematology Forum provides a collaborative environment for strategic focus and vision for Haematological Cancer services throughout the North of Scotland Health Boards.

Haematology cancer services in the North

Haemtatology is the study of blood cancers which are rare in Scotland, with approximately 700 new cases diagnosed in Scotland each year. The most common types are known as Leukaemia and Lymphoma.

In the North, Haematology cancer services are managed in our three cancer centres in Aberdeen, Dundee and Inverness.

The aim of this Pathway Board is to facilitate regional working between the centres, ensuring a focus on improving patient outcomes.

For more information on the symptoms, investigation and treatment of Haematological cancers, please visit the NHS Inform website.

Pathway Board details

Clinical Director Vacant
Terms of Reference Published February 2019

Clinical Management Guidelines

Title Published
Adult Acute Lymphoblastic Leukaemia In Development
Acute Myeloid Leukaemia In Development
Chronic Lymphocytic Leukaemia November 2020
Chronic Myeloid Leukaemia In Development
CNS Prophylaxis in Lymphoid Malignancies In Development
DLBC Lymphoma In Development
Classical Hodgkin lymphoma In Development
Myeloma In Development
Mantle In Development
Scottish Consensus Clinical Management Guideline for Classical Hodgkin Lymphoma  
Scottish Consensus Clinical Management Guideline for Follicular Non-Hodgkin Lymphoma  
Scottish Consensus Clinical Management Guideline Chronic Lymphocytic Leukaemia  

NOTE: Documents marked * can only be accessed using an NHS networked device.

Other guidance

NICE Guideline 52 - Non-Hodgkin’s lymphoma: diagnosis and management

NICE Guideline 35 - Myeloma: diagnosis and management

Scottish Cancer Referral Guidelines - Haematological Cancers

Scottish Palliative Care Guidelines

North of Scotland Quality Performance Indicator (QPI) Annual Reports

Acute Leukaemia

Acute Leukaemia QPI Annual Report (2021-22 patients)
Acute Leukaemia QPI Annual Report (2020-21 patients)
Acute Leukaemia QPI Annual Report (2018-19 patients)
Acute Leukaemia QPI Annual Report (2017-18 patients)
Acute Leukaemia QPI Annual Report (2015-16 patients)
Acute Leukaemia QPI Annual Report (2014-15 patients)

Lymphoma

Lymphoma QPI Annual Report (2021-22 patients)
Lymphoma QPI Annual Report (2020-21 patients)
Lymphoma QPI Annual Report (2019-20 patients)
Lymphoma QPI Annual Report (2018-19 patients)
Lymphoma QPI Annual Report (2017-18 patients)
Lymphoma QPI Annual Report (2014-15 patients)
Lymphoma QPI Annual Report (2013-14 patients)

Quality Performance Indicator (QPI) National Reports

Acute Leukaemia

Acute Leukaemia QPI National Report (2017-20 patients)
Acute Leukaemia QPI National Report (2014-17 patients)

Lymphoma

Lymphoma QPI National Report (2013-16 patients)

Charities

Macmillan Cancer Support - Myeloma
Myeloma UK
Lymphoma Action
Macmillan Cancer Support - Lymphoma
Macmillan Cancer Support - Leukaemia
Leukaemia Care
Blood cancer UK